Clinical experience with CD64-directed immunotherapy. An overview

Curnow, Randall T.·1997·Cancer Immunology, Immunotherapy
DOI 10.1007/s002620050435

Cited by (141)

Items 101–141 of 141

  1. Recombinant bispecific single chain antibody fragments induce Fcγ-receptor-mediated elimination of CD30+ lymphoma cells
    Katharina Ranft, Theo Thepen, Rainer Fischer, Stefan Barth, Michael Stöcker · 2009 · Cancer Letters
  2. Bispecific Antibodies
    Dafne Müller, Roland E. Kontermann · 2007 · Wiley eBooks
  3. Monoclonal antibody therapy
    Robert Owen Dillman · 2009 · Springer eBooks
  4. Specific Targeting Immunotherapy of Cancer with Bispecific Antibodies.
    Toshio Kudo, Masanori Suzuki, Yu Katayose, Masao Shinoda, Naoki Sakurai, Hideaki Kodama, Masahiko Ichiyama, Shinichi Takemura, Hiroshi Yoshida, Hisaaki Saeki et al. · 1999 · The Tohoku Journal of Experimental Medicine
  5. The Role of Growth Factors for Disease and Therapy in Diseases of the Head and Neck
    Orlando Guntinas‐Lichius, Claus Wittekindt · 2003 · DNA and Cell Biology
  6. Immunological aspects of head and neck cancer: Biology, pathophysiology and therapeutic mechanisms
    Alasdair J. McKechnie, R. A. Robins, Oleg Eremin · 2004 · The Surgeon
  7. Bispecific Antibodies
    Dafne Müller, Roland E. Kontermann · 2014 · Wiley eBooks
  8. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment
    Justyn Fine, Bunyarit Meksiriporn, Jiacheng Tan, Jamie B. Spangler · 2024 · Annual Review of Chemical and Biomolecular Engineering
  9. Bispecific Antibodies: Developments and Current Perspectives
    Roland E. Kontermann · 2011 · Springer eBooks
  10. Bispecific Antibodies from Hybrid Hybridoma
    Gerhard Moldenhauer · 2011 · Springer eBooks
  11. Prognostic histological and immune markers of renal cell carcinoma
    Tamás Magyarlaki, István Buzogány, László Kaiser, Farkas Sükösd, Róbert Döbrönte, Barbara F. Simon, Attila Fazekas, Judit Nagy · 2001 · Pathology & Oncology Research
  12. CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1
    Yingying Qi, Weiyan Zhu, Kexin Mo, Hui Jiang · 2024 · Journal of Cancer Research and Clinical Oncology
  13. Tyrosine Kinase Inhibitors and Cancer Therapy
    Srinivasan Madhusudan, Trivadi Sundaram Ganesan · 2007 · Springer eBooks
  14. The Immunophenotype of Bone Marrow Lymphocytes in Children with Immune Thrombocytopenic Purpura
    Samin Alavi, Zahra Aryan, Farid Ghazizadeh, Nahid Arabi, Mahin Nikougoftar, Maryam Ebadi · 2014 · Pediatric Hematology and Oncology
  15. Therapeutic Antibodies and Immunologic Conjugates
    Nai‐Kong V. Cheung · 2014 · Elsevier eBooks
  16. ErbB-targeted therapeutic approaches in human cancer
    Carlos L. Arteaga · 2003 · Elsevier eBooks
  17. A two-step culture process for generating abundant CD14+ monocytes from human hematopoietic stem cells
    Tsung-Yu Tseng, Li-Cheng Lu, Hsing-Fen Tsai, Keng‐Fu Hsu, Ching-Min Chuang, Yu-Ting Wang, Yi-Ting Lai, Chao‐Ling Yao · 2023 · Journal of the Taiwan Institute of Chemical Engineers
  18. Effector Cell Recruitment by Bispecific Antibodies
    Christian Kellner, Matthias Peipp, Thomas Valerius · 2011 · Springer eBooks
  19. Therapeutic Antibodies and Immunologic Conjugates
    Konstantin Dobrenkov, Nai‐Kong V. Cheung · 2020 · Elsevier eBooks
  20. Approaches to optimize the use of monoclonal antibodies to epidermal growth factor receptor
    Emiliano Calvo, Eric Keith Rowinsky · 2005 · Current Oncology Reports
  21. Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
    Tove Olafsen, Charlotte K. Munthe Lund, Øyvind Sverre Bruland, Inger Sandlie, Terje Einar Michaelsen · 1999 · Cancer Immunology Immunotherapy
  22. Oral vaccination with autologous platelets in chronic autoimmune thrombocytopenic purpura
    Gerardo Julio Hermida, R. Manjón, F. Casanova, M. Rodriguez-Salazar · 2001 · Medical Hypotheses
  23. Monoklonale Antikörper: Entwicklung und klinische Perspektiven
    Peter Borchmann, Gert Riethmüller, Andreas Engert · 2001 · Der Internist
  24. GM-CSF as adjuvant for immunotherapy with bispecific antibodies
    David Elsässer, H. Stadick, Jan G. J. van de Winkel, Thomas Valerius · 1999 · European Journal of Cancer
  25. Cancer therapies targeted to the epidermal growth factor receptor and its family members
    Susan E. Kane · 2006 · Expert Opinion on Therapeutic Patents
  26. Nonclinical Development of Multi-targeting Biopharmaceuticals
    Rodney A. Prell, Donna W. Lee, Wendy Halpern, Anu V. Connor · 2013 · Elsevier eBooks
  27. Bispezifische Antik�rper in der H�matologie und Onkologie
    Roland Repp, Thomas Valerius, Ralf Christian Bargou · 2001 · Der Internist
  28. Antibody-Mediated Drug Delivery in Cancer Therapy
    Zhenping Zhu, Daniel J. Hicklin · 2004 · Humana Press eBooks
  29. Surfactant protein D/anti-Fc receptor bifunctional proteins as a tool to enhance host defence
    Esther C.W. Breij, Joseph J. Batenburg · 2008 · Expert Opinion on Biological Therapy
  30. Effective Cancer Immunotherapy – Are We There Yet?
    J. Lynne Williams, Evon Kashat · 2015 · American Society for Clinical Laboratory Science
  31. Novel Applications of Bispecific DART® Proteins
    Syd Johnson, Bhaswati Barat, Hua W. Li, Ralph F. Alderson, Paul A. Moore, Ezio Bonvini · 2013
  32. Bispecific Antibodies for the Retargeting of Cytokines
    Bruno Robert, Christel Larbouret, D. Azria, Jean‐Pierre Mach, André Pèlegrin · 2011 · Springer eBooks
  33. Development of multifunctional solid lipid nanoparticles for theranostic applications in rheumatoid arthritis
    João Albuquerque · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  34. Antibody therapy of cancer
    Mandy Gruijs · 2023
  35. EGFR-Directed Monoclonal Antibodies
    Roberto Bianco, Teresa Gelardi, Sonia Garofalo, Roberta Rosa, Giampaolo Tortora · 2009 · Springer eBooks
  36. Treatment with Monoclonal Antibodies
    Gisela M. Schwab, Lorin K. Roskos, Clay Davis · 2004 · Humana Press eBooks
  37. Expression and characterisation of biopharmaceuticals in heterologous expression systems
    Antje Paetz, Rainer Fischer · 2005 · RWTH Publications (RWTH Aachen)
  38. Expression and in vitro characterisation of human Granzyme B-based immunotherapeutics for specific targeting of CD64 + malignancies
    Bettina Stahnke, Rainer Fischer · 2011 · Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft)
  39. Therapeutic Antibodies and Immunologic Conjugates
    Nai‐Kong V. Cheung · 2008 · Elsevier eBooks
  40. Application value of combined detection of serum IL-6, SDF-1 and CD64 in the diagnosis of early postoperative infection after limb fractures
    Tong Liu, Dajiang Xin · 2023 · Biotechnology and Genetic Engineering Reviews
  41. CRISPR/Cas9-based genome-wide screening for Metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1
    Hui Jiang, Yingying Qi, Ting Zhang, Weiyan Zhu · 2023 · Research Square